2-((R)-4-((3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)acetic acid-D5; N-[(3.alpha.,5.beta.,7.beta.)-3,7-dihydroxy-24-oxocholan-24-yl]Glycine-D5; 3.alpha.,7.beta.-Dihydroxy-5.beta.-cholanoylglycine-D5; Glycylursodeoxycholic acid-D5; N-(3.alpha.,7.beta.-Dihydroxy-5.beta.-cholan-24-oyl)glycine-D5; N-[(3.alpha.,5.beta.,7.beta.)-3,7-Dihydroxy-24-oxocholan-24-yl]glycine-D5; Ursodeoxycholylglycine-D5; Glycoursodiol
Glycoursodeoxycholic Acid-d5 is a fully characterized chemical compound used as a reference standard of API Ursodiol. The standard offered is compliant with regulatory guidelines. Glycoursodeoxycholic Acid-d5 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 64480-66-6 (non-d)
